Status | Study |
Recruiting |
Study Name: Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults Condition: Hemorrhagic Fever, Ebola Date: 2015-09-29 Interventions: Biological: Ad26.ZEBOV One 0.5 |
Active, not recruiting |
Study Name: Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) Condition: Prevention of Ebola Infection Date: 2015-07-17 Interventions: Biological: V920 Consistency Lot A |
Recruiting |
Study Name: Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up Condition: Ebola Virus Disease Date: 2015-04-30 |
Enrolling by invitation |
Study Name: Multiple Treatments for Ebola Virus Disease (EVD) Condition: Ebola Virus Disease Date: 2015-03-01 Interventions: Drug: Azithromycin Adults (> |
Completed |
Study Name: STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) Condition: Hemorrhagic Fever, Ebola Date: 2015-02-19 Interventions: Biological: rVSVΔG-ZEBOV The rVSVΔG-ZEBOV vaccine is comprised of a single recombinant VSV iso |
Completed |
Study Name: Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects Condition: Ebola Date: 2015-02-10 Interventions: Biological: Base Dose EBOV GP Vaccine Biol |
Active, not recruiting |
Study Name: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda Condition: Hemorrhagic Fever, Ebola Date: 2015-01-29 Interventions: Biological: cAd3-EBOZ cAd3 vac |
Active, not recruiting |
Study Name: Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) Condition: Ebola Virus Date: 2015-01-22 Interventions: Biological: VSVG-ZEBOV The VSV |
Completed |
Study Name: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea Condition: Hemorrhagic Fever, Ebola Date: 2015-01-12 Interventions: Other: Convalescent Plasma Patients will be treated with plasma from recovered EVD patients. |
Completed |
Study Name: A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. Condition: Ebola Virus Disease Date: 2014-12-22 Interventions: Biological: Low dose Ebola Zaire vaccine (Ad5-EBOV) |